Abstract
EXPANSION, ACTIVATION AND FUNCTION PROMOTION OF MYELOID-DERIVED SUPPRESSOR CELLS IN ADJUVANT-INDUCED ARTHRITIS

Sahar Sobhy Abd-Elhalem*

ABSTRACT

The role of myeloid-derived suppressor cells (MDSCs) in autoimmune diseases is starting to be elucidated. No previous studies demonstrate the role of these cells in adjuvant-induced arthritis (AA) rat model. MDSCs are one of the main cell populations that negatively regulate immune responses. Thus, MDSC targeting represents a promising tool to increase the efficacy of immune-based therapies. The objective of the present study was not only to investigate the role of myeloid-derived suppressor cells in AA rat model, but also to clarify the correlation between these cells and some factors which may promote their expansion, activation and suppressive activity. Body weight gain, white blood cells count, serum antinuclear autoantibodies, flow cytometry for MDSCs percentage in peripheral blood, serum IL-6, macrophage-colony stimulating factor (M-CSF), inducible nitric oxide synthase (iNOS) and arginase-1 were assessed in both control group and AA rat model supported by a histopathological study on joints. Results of the current study established for the first time the elevation of MDSCs percentage in AA rat model suggesting their possible potential role in the disease. Also, there is a positive correlation between increase in MDSCs percentage and elevated serum levels of IL-6, M-CSF, iNOS and arginase-1.

Keywords: Myeloid-Derived Suppressor Cells, Adjuvant-Induced Arthritis, IL-6, macrophage-colony stimulating factor.


[Full Text Article]   [Download Certificate]

Indexing

Best Article Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: JULY ISSUE PUBLISHED

    JULY 2026 Issue has been successfully launched on 1 JULY 2026.

  • EJBPS: New Impact Factor 2026

    EJBPS Impact Factor has been Increased from  7.482 to 8.181 for Year 2026.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

Google Scholar Index Copernicus Indian Science Publications Urlich's Periodicals Directory, Proquest, UK (In Process) Research Bible, Fuchu, Tokyo. JAPAN UDLedge Science Citation Index International Society for Research activity (ISRA) Scientific Indexing Services (SIS) InfoBase Index (In Process) SJIF Impact Factor Scholar Article Impact Factor, SAIF Universal Impact Factor CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Global Impact Factor (GIF) (0.377) IP Indexing (IP Value 3.77) Web of Science Group (Under Process) Directory of Research Journals Indexing Scope Database Academia Academia Doi-Digital Online Identifier Doi-Digital Online Identifier ISSN National Centre Zenodo Indexing International CODEN Service, USA

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT